Identification of novel inhibitors of dietary lipid absorption using zebrafish

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Clifton, Justin D ^a   Lucumi, Edinson ^b   Myers, Michael C ^b   Napper, Andrew ^b   Hama, Kotaro ^c   Farber, Steven A ^c   Smith III, Amos B ^b   Huryn, Donna M ^b   Diamond, Scott L ^b   Pack, Michael ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GEOPHYSICAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL DERIVATIVE; CLOFAZIMINE; EZETIMIBE; LONG CHAIN FATTY ACID; PHOSPHOLIPID DERIVATIVE; PROTEINASE; TETRAHYDROLIPSTATIN; AZETIDINE DERIVATIVE; CHOLESTEROL; DRUG DERIVATIVE; FATTY ACID; FLUORESCENT DYE; PHOSPHOLIPID;

ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; EMBRYO; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME MECHANISM; FAT INTAKE; FATTY ACID METABOLISM; FLUORESCENCE ANALYSIS; IN VIVO STUDY; LARVAL STAGE; LIPID ABSORPTION; LIPID ANALYSIS; NONHUMAN; ZEBRA FISH; ABSORPTION; ANIMAL; CHEMISTRY; FEASIBILITY STUDY; HUMAN; LARVA; LIPID METABOLISM; METABOLISM; MOLECULAR LIBRARY;

DANIO RERIO; MAMMALIA;

ABSORPTION; ANIMALS; AZETIDINES; CHOLESTEROL; DIETARY FATS; DRUG EVALUATION, PRECLINICAL; ENDOCYTOSIS; FATTY ACIDS; FEASIBILITY STUDIES; FLUORESCENT DYES; HUMANS; LARVA; LIPID METABOLISM; PHOSPHOLIPIDS; SMALL MOLECULE LIBRARIES; ZEBRAFISH;

EID: 77957867766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012386     Document Type: Article

References (50)

1. Kiortsis DN, Filippatos TD, Elisaf MS (2005) The effects of orlistat on metabolic parameters and other cardiovascular risk factors. Diabetes Metab 31: 15-22.
2. Nakou ES, Filippatos TD, Kiortsis DN, Derdemezis CS, Tselepis AD, et al. (2008) The effects of ezetimibe and orlistat, alone or in combination, on highdensity lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia. Expert Opin Pharmacother 9: 3151-3158.
3. Nakou ES, Filippatos TD, Georgoula M, Kiortsis DN, Tselepis AD, et al. (2008) The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia. Curr Med Res Opin 24: 1919-1929.
4. Athyros VG, Tziomalos K, Kakafika AI, Koumaras H, Karagiannis A, et al. (2008) Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients. Am J Cardiol 101: 483-485.
5. Dujovne CA, Ettinger MP, McNeer JF, Lipka LJ, LeBeaut AP, et al. (2002) Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol 90: 1092-1097.
6. Kastelein JJ, Akdim K, Stroes ES, Zwinderman AH, Bots ML, et al. (2008) Simvastatin with or without ezetimibe in familial hyper-cholesterolemia. N Engl J Med 358: 1431-1443.
7. Brown BG, Taylor AJ (2008) Does ENHANCE diminish confidence in lowering LDL or in ezetimibe? N Engl J Med 358: 1504-1507.
8. Rossebø AB (2008) Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359: 1343-1356.
9. Fazio S, Guyton JR, Polis AB, Adewale AJ, Tomassini JE, et al. (2010) Long-Term Safety and Efficacy of Triple Combination Ezetimibe/Simvastatin Plus Extended-Release Niacin in Patients With Hyperlipidemia. Am J Cardiol 105: 487-494.
10. Mitka M (2010) Cholesterol drug lowers LDL-C levels but again fails to show clinical benefit. JAMA 303: 211-212.
11. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, et al. (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4: 33-41.
12. Shestopalov IA, Sinha S, Chen JK (2007) Light-controlled gene silencing in zebrafish embryos. Nat Chem Biol 3: 650-651.
13. Esengil H, Chang V, Mich JK, Chen JK (2007) Small-molecule regulation of zebrafish gene expression. Nat Chem Biol 3: 154-155.
14. Bayliss PE, Bellavance KL, Whitehead GG, Abrams JM, Aegerter S, et al. (2006) Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish. Nat Chem Biol 2: 265-273.
15. Stern HM, Murphey RD, Shepard JL, Amatruda JF, Straub CT, et al. (2005) Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol 1: 366-370.
16. Burns CG, Milan DJ, Grande EJ, Rottbauer W, MacRae CA, Fishman MC (2005) High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol 1: 263-264.
17. Sheridan MA (1986) Lipid dynamics in fish: aspects of absorption, transportation, deposition and mobilization. Comp Biochem Physiol B 90: 679-90.
18. Schlegel A, Stainier DY (2006) Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae. Biochemistry 45: 15179-15187.
19. Farber SA, Pack M, Ho SY, Johnson ID, Wagner DS, et al. (2001) Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science 292: 1385-1388.
20. Kadereit B, Kumar P, Wang WJ, Miranda D, Snapp EL, et al. (2008) Evolutionarily conserved gene family important for fat storage. Proc Natl Acad Sci U S A 105: 94-99.
21. Parizhskaya M, Youssef NN, Di Lorenzo C, Goyal RK (2001) Clofazimine enteropathy in a pediatric bone marrow transplant recipient. J Pediatr 138: 574-576.
22. Field SK, Cowie RL (2003) Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine. Chest 124: 1482-1486.
23. Davis HR, Jr., Altmann SW (2004) Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of wholebody cholesterol homeostasis. J Biol Chem 279: 33586-33592.
24. Altmann SW, Davis HR, Jr., Zhu LJ, Yao X, Hoos LM, et al. (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303: 1201-1204.
25. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, et al. (2005) The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 102: 8132-8137.
26. Davies JP, Ioannou YA (2006) The role of the Niemann-Pick C1-like 1 protein in the subcellular transport of multiple lipids and their homeostasis. Curr Opin Lipidol 17: 221-226.
27. Ge L, Wang J, Qi W, Miao HH, Cao J, et al. (2008) The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab 7: 508-519.
28. Kampf JP, Kleinfeld AM (2007) Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane. Physiology 22: 7-14.
29. Farell JJ (2006) Digestion and Absorption of Nutrients and Vitamins. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastronintestinal and Liver Disease. Philadelphia: W. B. Saunders. Pp 2150-2160.
30. Gaffield MA, Betz WJ (2006) Imaging synaptic vesicle exocytosis and endocytosis with FM dyes. Nat Protoc 1: 2916-2921.
31. Matthews RP, Plumb-Rudewiez N, Lorent K, Gissen P, Johnson CA, et al. (2005) Zebrafish vps33b, an ortholog of the gene responsible for human arthrogryposis-renal dysfunction-cholestasis syndrome, regulates biliary development downstream of the onecut transcription factor hnf6. Development 132: 5295-5306.
32. Hama K, Provost E, Baranowski TC, Rubinstein AL, Anderson JL, et al. (2009) In vivo imaging of zebrafish digestive organ function using multiple quenched fluorescent reporters. Am J Physiol Gastrointest Liver Physiol 296: G445-453.
33. Guerciolini R (1997) Mode of action of orlistat. Int J Obes Relat Metab Disord 21 Suppl 3: S12-23.
34. Hawes BE, O'Neill KA, Yao X, Crona JH, Davis HR, Jr., et al. (2007) In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs Mol Pharmacol 71: 19-29.
35. Weinglass AB, Kohler M, Schulte U, Liu J, Nketiah EO, et al. (2008) Extracellular loop C of NPC1L1 is important for binding to ezetimibe. Proc Natl Acad Sci U S A 105: 11140-11145.
36. Ostrom RS, Liu X (2007) Detergent and detergent-free methods to define lipid rafts and caveolae. Methods Mol Biol 400: 459-468.
37. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K (1999) Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell 10: 961-974.
38. Mayor S, Pagano RE (2007) Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8: 603-612.
39. Jones KS, Alimov AP, Rilo HL, Jandacek RJ, Woollett LA, Penberthy WT (2008) A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development. Nutr Metab 27: 5-23.
40. Dufresne M, Seva C, Fourmy D (2006) Cholecystokinin and gastrin receptors. Physiol Rev 86: 805-847.
41. Miller LJ, Dong M, Harikumar KG, Lisenbee CS (2007) Biochemical and cell biological mechanisms of cholecystokinin receptor regulation. Curr Top Med Chem 7: 1166-1172.
42. Cheng ZJ, Miller LJ (2001) Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 276: 48040-48047.
43. Labonté ED, Camarota LM, Rojas JC, Jandacek RJ, Gilham DE, et al. (2008) Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l12/2 mice. Am J Physiol Gastrointest Liver Physiol 295: G776-783.
44. Yamaoka-Tojo M, Tojo T, Kosugi R, Hatakeyama Y, Yoshida Y, et al. (2009) Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia. Lipids Health Dis 12: 8:41.
45. Field FJ, Watt K, Mathur SN (2007) Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells. J Lipid Res 48: 1735-1745.
46. Béaslas O, Cueille C, Delers F, Chateau D, Chambaz J, et al. (2009) Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1. PLoS ONE 4: e4278.
47. Liu Y, Ordovas JM, Gao G, Province M, Straka RJ, et al. (2008) The SCARB1 gene is associated with lipid response to dietary and pharmacological interventions. J Hum Genet 53: 709-717.
48. Tanaka T, Delgado-Lista J, Lopez-Miranda J, Perez-Jimenez F, Marin C, et al. (2007) Scavenger receptor class B type I (SCARB1) c.1119C.T polymorphism affects postprandial triglyceride metabolism in men. J Nutr 137: 578-582.
49. Pérez-Martínez P (2004) Postprandial lipemia is modified by the presence of the polymorphism present in the exon 1 variant at the SR-BI gene locus. J Mol Endocrinol 32: 237-245.
50. Wallace KN, Pack M (2003) Unique and conserved aspects of gut development in zebrafish. Dev Biol 255: 12-29.